Navigation Links
Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease

Indian pharma major Dr. Reddy's Laboratories will launch a first-of-its-kind pill to tackle heart diseases in the second half of 2007, it was announced Thursday. //

The company has teamed up with researchers at University of Auckland, New Zealand, for trials of the groundbreaking 'polypill' that combines four medicines including aspirin and statin, commonly used to treat heart ailments.

India records nearly 2.8 million deaths a year due to cardio-vascular diseases.

'Trials in India are underway. We are conducting trials on 220 patients and after testing on 440 more cases, the product will be launched in the Indian market,' said Satish Reddy, managing director of Dr. Reddy's Lab.

'We have already received the necessary approval from the government for conducting the trails. We hope the product will be available to masses in the second quarter of 2007,' he told reporters at the New Zealand High Commission here.

'This is first-of-its-kind drug in the world to tackle heart problem and will open newer vistas to handle such ailments,' Reddy told IANS, adding it will cost Rs.100 for 30 tablets.

New Zealand's High Commissioner to India Graeme Waters said: 'This project holds open the possibility of revolutionising an important aspect of healthcare in both developing and developed countries.'

The new drug will be cheaper to administer and more effective in preventing strokes and heart attacks, said Anthony Rodgers, a researcher at Auckland University.

The trial aims to confirm that the polypill is effective in lowering cholesterol and blood pressure - known causes of heart attacks and strokes.

The Health Research Council of New Zealand invested NZ$350,000 to support the overall co-ordination of the trial and recruitment in New Zealand. Dr. Reddy's will invest NZ$ 7.5 million in developing the polypill and providing supplies for clinical trials globally.

Source- IANS
'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
3. Dr. Reddys To Invest $100 Mn In Andhra
4. Dr Reddys Eyeing for Generics Arm of Merck
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Nutrient Profiling System Launched By Food Officials in UK
7. New Oat And Soy-Based Fat Replacer Launched
8. Launch Of India’s First Virology Course At Pun
9. Race Based Genome Project Launched By Mexico
10. Bird flu In Indonesia: Government To Launch ‘Village Preparedness’ Schee
11. Action Plan Against Drug Deaths Launched
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... , ... “A Respectful Response To Atheist Manifesto”: theological refutation ... is the creation of published author Richard Hostetter, a former missionary in Africa ... graduate degrees from Kent State University and the University of Ghana. , Published ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... publication of the first issue of its companion print magazine. The new magazine, ... cosmetic surgery thanks to information provided by board-certified doctors from across the country. ...
(Date:3/22/2017)... ... ... Old School Labs™, makers of the best-selling Vintage line of natural sports ... who trained with Floyd Mayweather, made his professional debut in London in 2003 and ... number of wins in contests in Britain, Germany and the U.S. , “We ...
(Date:3/22/2017)... ... March 22, 2017 , ... Influence Health, the ... solutions have enabled Children’s Hospital of The King’s Daughters (CHKD) to achieve a ... value of a digital marketing approach, the 206-bed pediatric teaching hospital in Norfolk, ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... research collaboration to translate advances in basic neuroscience at the BMRI labs into ... collaboration seeks to improve movement, vision, and cognition impaired by stroke, traumatic brain ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Insight 2022" drug pipelines to their offering. ... Global Immune ... gives comprehensive insight on clinical and non-clinical aspects involved in ... main streamline drugs in the immunotherapy treatment. Report helps to ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their ... The ... of around 7.1% over the next decade to reach approximately $129.81 ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ( ... to drug research and development, today announced the ... QSP Day 2017 is a day full of ... systems pharmacology (QSP) community. The focus is to ... de-risking and accelerating drug research and development. ...
Breaking Medicine Technology: